Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| tat Gene Products, Human Immunodeficiency Virus | 6 | 2021 | 13 | 1.700 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 7 | 2022 | 82 | 1.660 |
Why?
|
| HIV-1 | 6 | 2022 | 177 | 1.620 |
Why?
|
| Cocaine | 9 | 2017 | 555 | 1.090 |
Why?
|
| Central Nervous System Agents | 3 | 2014 | 37 | 1.070 |
Why?
|
| Alkaline Ceramidase | 7 | 2010 | 35 | 1.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2014 | 124 | 0.970 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 79 | 0.910 |
Why?
|
| Dopamine Uptake Inhibitors | 5 | 2017 | 152 | 0.790 |
Why?
|
| Antigens, Nuclear | 2 | 2022 | 24 | 0.780 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2014 | 435 | 0.770 |
Why?
|
| Cocaine-Related Disorders | 3 | 2014 | 504 | 0.760 |
Why?
|
| Nucleus Accumbens | 3 | 2014 | 417 | 0.740 |
Why?
|
| HIV Infections | 2 | 2019 | 791 | 0.710 |
Why?
|
| Prefrontal Cortex | 6 | 2015 | 640 | 0.680 |
Why?
|
| Autoimmunity | 1 | 2020 | 118 | 0.680 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 219 | 0.670 |
Why?
|
| Point Mutation | 1 | 2019 | 97 | 0.650 |
Why?
|
| Receptors, AMPA | 3 | 2014 | 99 | 0.650 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2015 | 175 | 0.620 |
Why?
|
| Drug-Seeking Behavior | 4 | 2014 | 213 | 0.620 |
Why?
|
| Synapsins | 2 | 2014 | 11 | 0.600 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2022 | 756 | 0.590 |
Why?
|
| Corpus Striatum | 2 | 2015 | 279 | 0.530 |
Why?
|
| Behavior | 1 | 2015 | 59 | 0.510 |
Why?
|
| Self Administration | 6 | 2014 | 419 | 0.450 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2013 | 3 | 0.440 |
Why?
|
| Dopamine | 5 | 2022 | 474 | 0.430 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 93 | 0.420 |
Why?
|
| Integrin beta1 | 2 | 2010 | 48 | 0.410 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 415 | 0.390 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 266 | 0.370 |
Why?
|
| Amidohydrolases | 2 | 2007 | 60 | 0.360 |
Why?
|
| Phosphorylation | 6 | 2020 | 1200 | 0.360 |
Why?
|
| Animals | 16 | 2022 | 20881 | 0.340 |
Why?
|
| Signal Transduction | 3 | 2020 | 2689 | 0.340 |
Why?
|
| Keratinocytes | 2 | 2010 | 68 | 0.310 |
Why?
|
| Cell Membrane | 1 | 2010 | 525 | 0.310 |
Why?
|
| Rats | 8 | 2022 | 5300 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2015 | 2083 | 0.300 |
Why?
|
| AIDS Dementia Complex | 2 | 2019 | 20 | 0.300 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 1 | 2007 | 39 | 0.300 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2550 | 0.290 |
Why?
|
| Calcium | 2 | 2010 | 929 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 284 | 0.270 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 1242 | 0.270 |
Why?
|
| Mutation | 5 | 2022 | 1213 | 0.250 |
Why?
|
| Analysis of Variance | 3 | 2017 | 1040 | 0.230 |
Why?
|
| Golgi Apparatus | 3 | 2010 | 75 | 0.230 |
Why?
|
| MicroRNAs | 2 | 2020 | 447 | 0.220 |
Why?
|
| Symporters | 1 | 2022 | 27 | 0.210 |
Why?
|
| Sphingosine | 3 | 2010 | 315 | 0.200 |
Why?
|
| Histidine | 2 | 2022 | 17 | 0.200 |
Why?
|
| Ceramides | 3 | 2010 | 578 | 0.190 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 30 | 0.180 |
Why?
|
| Ceramidases | 3 | 2010 | 47 | 0.180 |
Why?
|
| Feces | 1 | 2020 | 88 | 0.180 |
Why?
|
| Substrate Specificity | 3 | 2010 | 234 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 2791 | 0.180 |
Why?
|
| Humans | 17 | 2022 | 68618 | 0.170 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 434 | 0.170 |
Why?
|
| Protein Binding | 3 | 2017 | 1027 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 223 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 144 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 532 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 507 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 122 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2010 | 282 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 331 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 2 | 2010 | 148 | 0.150 |
Why?
|
| Male | 9 | 2022 | 37321 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2010 | 682 | 0.150 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 58 | 0.140 |
Why?
|
| CREB-Binding Protein | 2 | 2015 | 10 | 0.140 |
Why?
|
| Lysophospholipids | 2 | 2010 | 209 | 0.140 |
Why?
|
| Kinetics | 3 | 2016 | 1047 | 0.140 |
Why?
|
| Ligands | 1 | 2017 | 317 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2013 | 954 | 0.130 |
Why?
|
| Mice | 4 | 2022 | 8474 | 0.130 |
Why?
|
| Synaptosomes | 1 | 2015 | 57 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1864 | 0.130 |
Why?
|
| Environment | 1 | 2015 | 115 | 0.120 |
Why?
|
| Locomotion | 1 | 2015 | 135 | 0.120 |
Why?
|
| Nicotinic Agonists | 1 | 2015 | 111 | 0.120 |
Why?
|
| Thionucleotides | 1 | 2013 | 21 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 67 | 0.110 |
Why?
|
| Cell Line | 1 | 2017 | 1752 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 39 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2013 | 67 | 0.110 |
Why?
|
| Oxytocin | 1 | 2014 | 124 | 0.110 |
Why?
|
| Cell Division | 3 | 2010 | 541 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2014 | 324 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 2013 | 223 | 0.100 |
Why?
|
| Nicotine | 1 | 2015 | 350 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2013 | 202 | 0.100 |
Why?
|
| Cues | 2 | 2013 | 654 | 0.100 |
Why?
|
| Receptor, trkB | 1 | 2011 | 27 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2010 | 447 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2022 | 237 | 0.090 |
Why?
|
| Fenretinide | 1 | 2010 | 26 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.090 |
Why?
|
| Lysosome-Associated Membrane Glycoproteins | 1 | 2010 | 6 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 274 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 250 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2010 | 137 | 0.090 |
Why?
|
| Cytosol | 1 | 2010 | 123 | 0.090 |
Why?
|
| Cricetulus | 2 | 2022 | 98 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2673 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 322 | 0.080 |
Why?
|
| Cricetinae | 2 | 2022 | 262 | 0.080 |
Why?
|
| Apoptosis | 2 | 2020 | 1641 | 0.080 |
Why?
|
| Neutral Ceramidase | 1 | 2008 | 27 | 0.080 |
Why?
|
| Tyrosine | 2 | 2022 | 196 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 351 | 0.080 |
Why?
|
| Tretinoin | 1 | 2008 | 92 | 0.080 |
Why?
|
| Lipids | 1 | 2010 | 298 | 0.080 |
Why?
|
| Protein Transport | 1 | 2008 | 280 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2008 | 324 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2007 | 84 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1851 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 95 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1034 | 0.070 |
Why?
|
| Sphingolipids | 1 | 2010 | 337 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 384 | 0.070 |
Why?
|
| Acid Ceramidase | 1 | 2007 | 85 | 0.070 |
Why?
|
| PC12 Cells | 2 | 2016 | 36 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 493 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2016 | 362 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2010 | 237 | 0.060 |
Why?
|
| Binding Sites | 2 | 2016 | 631 | 0.060 |
Why?
|
| Brain | 1 | 2014 | 2176 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2016 | 546 | 0.060 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1070 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2022 | 40 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2022 | 22 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1664 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2022 | 276 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.050 |
Why?
|
| Female | 2 | 2022 | 38074 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2020 | 160 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 209 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 434 | 0.040 |
Why?
|
| Neoplasms | 1 | 2010 | 1667 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 38 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 137 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2015 | 24 | 0.030 |
Why?
|
| Tritium | 1 | 2015 | 101 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 104 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 18 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 161 | 0.030 |
Why?
|
| Reinforcement Schedule | 1 | 2014 | 59 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 96 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 396 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 326 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 247 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 320 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 190 | 0.030 |
Why?
|
| Piperazines | 1 | 2015 | 206 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 498 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2014 | 240 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 44 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 35 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 54 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 139 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2010 | 144 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 97 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 381 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 489 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 492 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 317 | 0.020 |
Why?
|
| Motivation | 1 | 2011 | 561 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.020 |
Why?
|
| Plasmids | 1 | 2006 | 258 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 375 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 266 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 782 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 629 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1083 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 483 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1447 | 0.010 |
Why?
|